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Objectives: Although infrequent, Grade C postoperative pancreatic fistulae (POPF) following pancreati-
coduodenectomy (PD) are morbid and potentially lethal. Traditional management of a disrupted pancre-
aticojejunostomy (PJ) anastomosis consists of either wide external drainage or completion
pancreatectomy. The aim of this study is to describe an alternative management approach to PJ
dehiscence after PD.
Methods: A bridge stent technique is employed in the setting of a disrupted PJ anastomosis. Upon
re-exploration, a 5-Fr or 8-Fr silastic feeding tube stent is placed across a gap between the jejunal
enterotomy and the pancreatic duct, and secured with an absorbable suture at both ends. Depending
upon the degree of local inflammation, this may be externalized by coursing the stent downstream
through the pancreaticobiliary drainage limb in a Witzel fashion.
Results: Over 8 years and 357 PDs with duct-to-mucosa PJ reconstruction, seven ISGPF (International
Study Group on Pancreatic Fistula) Grade C fistulae occurred (2%). Two patients ultimately died sec-
ondary to POPF (neither anastomosis was dehisced). The described technique was used in the other five
patients, all of whom had evidence of a dehisced PJ anastomosis. All originally had at least two or three
recognized risk factors for POPF development (high-risk pathology, soft gland, duct diameter 3 mm,
estimated blood loss 1000 ml). All patients survived this complication and were discharged from
hospital. There have been no longterm external fistulae, nor any recognized PJ strictures or remnant
atrophy (median follow-up: 10.7 months).
Conclusions: In the context of a dehisced pancreaticojejunal anastomosis, the bridge stent technique
is a safe and effective method of management that contributes to diminished mortality and helps to
salvage pancreatic function.
Keywords
pancreatic resection, outcomes, pancreatic neoplasia
Received 2 June 2010; accepted 22 July 2010
Correspondence
Tara S. Kent, Department of Surgery, Beth Israel Deaconess Medical Center, 330 Brookline Avenue,
Stoneman 9th Floor, Boston, MA 02215, USA. Tel: + 1 781 453 3650. Fax: + 1 781 453 3652. E-mail:
tkent@bidmc.harvard.edu
Introduction
Despite overall improvements in morbidity and mortality follow-
ing pancreaticoduodenectomy (PD), the clinically relevant pan-
creatic fistula remains problematic in terms of both management
and resource utilization. Pancreatic fistulae are now clearly
defined and graded according to the International Study Group
on Pancreatic Fistula (ISGPF) system1. The deleterious clinical
and economic impacts of Grade C postoperative pancreatic fistu-
lae (POPF), which are responsible for significant increases in
duration of hospitalization, use of services and total costs, have
been specifically demonstrated.2
The traditional mode of management of the overtly dehisced
pancreaticojejunostomy (PJ) involves surgical re-exploration with
such options as: wide external drainage; revision of the initial
pancreaticojejunal anastomosis; conversion to an alternative
This paper was presented at the International Hepato-Pancreato-Biliary
Association Meeting, 18–22 April 2010, Buenos Aires, Argentina.
DOI:10.1111/j.1477-2574.2010.00227.x HPB
HPB 2010, 12, 577–582 © 2010 International Hepato-Pancreato-Biliary Association
pancreaticoenteric anastomosis; intentional pancreatic ductal
occlusion, and even completion pancreatectomy.3–6 The
last of these has previously been advocated as the operation of
choice when the degree of inflammation precludes the safe
revision of the original anastomosis.3–6 However, it comes at a
price of absolute endocrine and exocrine insufficiency and still has
a significant mortality rate.3,5,6 Alternatively, although it is initially
safer and seemingly more efficient, wide external drainage
can be an incomplete solution that requires more interventions
and prolonged management.4 The aim of this study is to
present another option for the management of the dehisced pan-
creaticojejunal anastomosis, which may be more practical and
definitive in the setting of marked inflammation and/or an
unstable patient.
Materials and methods
With the approval of the institutional review board, a pancreatic
resection database was used to identify and review all patients who
underwent PDs with duct-to-mucosa PJ anastomosis our institu-
tion during 2001–2009. Of note, a two-layer duct-to-mucosa PJ
anastomosis is routinely employed, most often without stent
placement. Pancreatogastrostomy reconstruction is rarely utilized.
Patients who suffered a Grade C POPF were included for further
analysis. The initial operation with respect to POPF risk factors,
re-operative findings and clinical outcomes were annotated, as
were the outcomes of salvage procedures.
Establishment of the diagnosis
The preoperative diagnosis of PJ anastomotic dehiscence was
based on clinical decompensation with evidence of sepsis in con-
junction with radiographic findings by axial computed tomogra-
phy (CT) (Fig. 1) demonstrating peripancreatic gas with an
associated ‘gap’ between the jejunum and the pancreatic neck
transaction margin. In patients in whom an internalized pancre-
atic anastomotic stent was employed at the construction of the
original anastomosis, this stent may, on occasion, be found to have
obviously migrated into the peritoneal cavity (Fig. 2). Sepsis was
defined according to Annane et al. as documentation or visually
evident focus of infection in the setting of systemic inflammatory
response syndrome.7 Patients with CT evidence of POPF but
without obvious anastomotic dehiscence and with stable
haemodynamics typically underwent a trial of non-operative
management.
Details of the technique
Initial exploration, via the original bilateral subcostal incision, is
undertaken to confirm that the PJ anastomosis is, as suspected,
dehisced. The antecolic, isoperistaltic duodenojejunostomy is
typically able to be gently retracted laterally to the left, rather than
taken down. Care is taken to avoid damage to the transverse colon
or mesocolon. The anastomosis is evaluated for: the degree of
surrounding inflammation, abscess or necrosis; the extent of
anastomotic dehiscence (i.e. anterior vs. complete); the extent of
the gap between the pancreas and the jejunal limb, and the quality
of the pancreatic parenchyma and the jejunal serosa. The pancre-
atic remnant is debrided as far as is feasible to healthier, well-
vascularized tissue.
When a duct-to-mucosa anastomosis cannot be properly com-
pleted as a result of suboptimal conditions, the gap can be
‘bridged’ with a paediatric feeding tube (Fig. 3). This bridge con-
sists of a 5-Fr or 8-Fr silastic feeding tube stent that is placed
Figure 1 Axial computed tomography demonstrating peripancreatic
gas with an associated ‘gap’ (arrows) between the jejunum and the
pancreatic neck transaction margin
Figure 2 Computed tomography shows that a pancreatic anasto-
motic stent employed at the construction of the original anastomosis
has migrated into the peritoneal cavity
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across the space between the jejunal enterotomy and the pancre-
atic duct, and secured with an absorbable suture at both ends. The
stent size employed is dependent on the receptivity of the pancre-
atic duct, which is usually very small and can be extremely hard to
locate in such conditions. If possible, a larger 8-Fr stent is inserted,
thus establishing a larger-calibre channel. The minute (2 mm)
pancreatic duct may be difficult to access with the feeding tube
and care must be taken to avoid a false passage into the pancreatic
parenchyma. This difficulty can be addressed by first introducing
either a small lacrimal probe or biliary dilator into the duct. Some-
times a small glidewire can be introduced in the duct and the stent
employed using the Seldinger technique. The stent can then be
anchored in place on the pancreatic side with absorbable sutures
placed carefully in the usually friable parenchyma and then
applied to the stent.
On the jejunal side, the stent can be placed through the entero-
tomy employed for the original anastomosis and similarly secured
with an absorbable pursestring suture that is again fixed to the
stent. Internal stents should be crafted fairly short (6–8 cm at
most) in order to allow for ultimate evacuation via bowel peri-
stalsis. Alternatively, if external drainage is desired and is techni-
cally feasible, the stent can be externalized several centimetres
downstream through the pancreaticobiliary drainage limb in a
Witzel fashion and then externalized through the abdominal wall.
In some patients, the jejunum has been able to be approximated
‘en masse’ to the pancreatic parenchyma after the bridge stent has
been placed, but this is rarely practical. One or two self-suction
drains (19-Fr round) are typically placed for external drainage of
the surrounding inflammation or abscess and for added control of
any residual pancreatic secretion. Ultimately, an internally placed
stent will be dislodged and evacuated through the bowels once the
absorbable suture dissolves (over weeks or months). Alternatively,
an externalized stent can be removed many weeks later once total
recovery has been assured. The ultimate objective is to enable a
channel (‘neo-duct’) to develop from reactive repair around the
periphery of the stent, which will shunt secretions from the pan-
creatic remnant to the pancreaticobiliary limb.
Results
Over 8 years, 357 PDs were performed with duct-to-mucosa PJ
reconstruction. The overall incidence of POPF was 21.8% (n =
78); that of clinically relevant POPF was 12.6% (n = 45) (Fig. 4).
Seven ISGPF Grade C fistulae occurred (2.0%). Two of the
affected patients ultimately died secondarily to the effects of POPF
in the absence of an overt anastomotic dehiscence. One of these
patients had been satisfactorily discharged from hospital accord-
ing to the postoperative care path but was readmitted 12 h later in
extremis and died shortly thereafter. Autopsy demonstrated the
POPF. The other patient became severely septic as a result of the
Grade C POPF, but his family declined re-intervention and
he therefore died. The technique described above was used in the
other five patients, all of whom had evidence of a grossly dis-
rupted PJ anastomosis (Table 1). In four of these five patients, the
manifestation of fistula occurred while they were still in hospital
recovering from the index operation.
All five patients originally had at least two or three recognized
risk factors for POPF development (pathology other than pancre-
atic adenocarcinoma or pancreatitis, soft gland texture, PD diam-
eter 3 mm, estimated blood loss [EBL] 1000 ml8). Median
EBL during the second operation was 200 cc (range: 50–800 cc).
Median operative time was 180.5 min (range: 126–191 min).After
re-operation and repair, all patients survived the complication
and were discharged from hospital after a median duration of stay
of 41 days (range: 8–77 days). Over a median follow-up of 10.7
months (range: 5–68 months), there have been no longterm exter-
nal pancreatico-cutaneous fistulae, nor any recognized PJ stric-
tures or remnant atrophy. One patient, without a prior diagnosis
of diabetes, remains on oral hypoglycaemic agents postopera-
tively, but no patients have evidence of exocrine insufficiency.
Four of the patients are still alive.
Discussion
Although PJ dehiscence with a Grade C POPF is a rare complica-
tion of PD, it has significant clinical impact and implies excessive
cost.2,9 The operative management of a disrupted anastomosis is
among the most technically challenging procedures a pancreatic
specialist will encounter. The operative terrain is generally hin-
dered by significant inflammation from local sepsis and tissue
degradation. Often, the presentation is well into the recovery
course, and the integrity of the tissues is fragile. In addition, the
patient’s overall physiology is markedly compromised and his or
Figure 3 (A) Dehiscence of the pancreatico-jejunal anastomosis is illustrated. Note the gap between the pancreatic remnant and the jejunum.
(B) Bridge-Stent Technique with externalized stent, and external drain adjacent to gap. (C) Bridge-Stent Technique with internal stent and
external drain adjacent to gap
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her nutrition is suboptimal. To salvage this difficult predicament,
many options are available, ranging from wide external drainage
to anastomotic revision to completion pancreatectomy. In this
setting, less may be better.
Smith et al.6 reported their experience with completion pancre-
atectomy following pancreaticoduodenectomy for pancreatic
leak/fistula or haemorrhage. In most cases, completion pancreate-
ctomy was selected as the means of salvage because the severe
inflammation in the setting of PJ anastomotic dehiscence pre-
cluded safe revision. Of their 11 patients, seven (64%) died in the
postoperative period from sepsis and multisystem organ failure.
Completion pancreatectomy has also been reported as a salvage
procedure in combination with other techniques in the manage-
ment of associated peritonitis. Guéroult et al.3 described comple-
tion pancreatectomy, with a jejunal stump stoma and use of
capillary Mikulicz packing in the peripancreatic or pelvic space.
Of their eight patients, three died in the postoperative period from
multisystem organ failure, jejunal necrosis and leak, and splenic
vein erosion with hepaticojejunostomy and gastrojejunostomy
leak, respectively. Other results with respect to mortality vary
Pancreaticoduodenectomy, n = 357
POPF, n = 78 No POPF, n = 279
Grade A POPF
n = 33
Grade B POPF
n = 38
Grade C POPF
n = 7
Managementa
Antibiotics (29)
Percutaneous drain (7)
Parenteral nutrition (10)
Managementa
Re-operation (5)
Antibiotics (6)b
Percutaneous drain (1)
Parenteral nutrition (2)
Figure 4 Incidence and management of 78 cases of postoperative pancreatic fistulae (POPF) in 357 cases of pancreaticoduodenectomy.
aNot mutually exclusive; bOne patient died prior to initiation of any definitive therapy
Table 1 Patients managed with the bridge stent technique for Grade C postoperative pancreatic fistulae
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Diagnosis Ampullary adenoca Pancreatitis Ampullary adenoca Duodenal adenoca Renal cell metastases
Gland texture Soft Soft Soft Soft Soft
Duct size 6 mm 3 mm 2 mm 2 mm 4 mm
EBL (index operation) 400 cc 600 cc 550 cc 500 cc 200 cc
Timing of re-operation POD 11 POD 6 POD 16 POD 13 POD 7
Symptoms Sepsis Sepsis Sepsis Change in drain output
character
Abdominal pain after drain
removal
Gap 1.5 cm None 1 cm 2 cm 0.5 cm
Type of stent for bridge 8-Fr
Internal
5-Fr
External
5-Fr
Internal
8-Fr
External
5-Fr
External
Length of stay, days 41 51 77 8 21
Intensive care unit stay Yes Yes Yes No Yes
Organ failure Yes Yes Yes No Yes
Overall cost, US$ $152 957 $256 933 $377 156 $48 401 $85 208
EBL, estimated blood loss; POD, postoperative day
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widely, ranging from 0% to 38%.4,5,9 Compared with the now low
mortality rates in elective resections, the results following surgery
for this problem remain perhaps unreasonably high. This has led
some, like Büchler et al., to suggest that there is no longer a role for
completion pancreatectomy for Grade C pancreatic fistulae.10
Most groups, even those advocating completion pancreatec-
tomy, make note of its technical difficulty, particularly in terms of
operative time and blood loss.5,6 Some have purported that resect-
ing the remnant pancreas in this situation, although morbid, is
more expeditious and ultimately more definitive. For instance, a
comparison of 21 patients undergoing re-exploration and drain-
age for PJ leak/dehiscence after pancreaticoduodenectomy vs.
eight patients undergoing completion pancreatectomy found that
patients in the drainage group were more likely to require addi-
tional re-explorations and had a significantly longer length of stay
and higher mortality (38% vs. 0%, respectively).4 An alternative
modification of completion pancreatectomy, in which a small
remnant of the distal pancreas is left in situ, may limit the devel-
opment of diabetes, but results in higher morbidity and mortal-
ity.11 Pancreatogastrostomy has also recently been proposed as an
alternative salvage operation in this setting and has been utilized
successfully in a small group of patients;12 however, the feasibility
of this approach depends on the adequacy of the pancreatic
remnant and is likely to require additional dissection in the
severely inflamed field. Often, this is technically impossible.
The rationale for the use of this approach developed in
response to the perils of re-operating on the pancreas in this
unfavourable setting of aggressive local sepsis. The stakes are high
for both patient and surgeon, particularly now that limited mor-
tality is expected as a quality measure of surgical performance.
In our patients, it was readily evident that revision and
re-anastomosis were risky if not impossible, given the extent of
separation and/or the tissue quality. However, the procedure may
represent an improvement over the more conservative, and
perhaps more common, option of wide local drainage or the more
drastic option of completion pancreatectomy. The goal of this
‘bridge stent’ technique is to effectively divert most, if not all, of
the pancreatic exocrine secretion internally rather than externally.
This scenario differs greatly from that in which stent placement
across a duct-to-mucosa PJ anastomosis may be considered at the
index operation to either protect or facilitate the precise construc-
tion of a delicate anastomosis. In fact, several prospective studies
of PJ anastomotic stenting at the time of PD have yielded confus-
ing results, showing, for example: a decreased rate of POPF with
externalized stents but no change in morbidity, mortality or need
for re-operation;13 a fistula rate in soft glands with stents double
that in soft glands without stents,14 and no difference in fistula rate
between (internally) stented and non-stented patients.15
Given this context, stenting was selectively used at the time
of PD. However, the bridge stent is distinct; in effect, a ‘neo-
anastomosis’ is developed over a short distance (<1 cm), relying
on a fibrotic wall developing around the channel created by the
silastic stent.
In terms of intensive care unit requirements and organ system
failure, the five patients in this series were as physiologically
impaired as most patients with a PJ dehiscence previously
reported in the literature, and their overall length of hospitaliza-
tion and associated costs were greatly increased, as would be
expected.However, each was ultimately able to be discharged from
the hospital. After nearly 2 years of follow-up, four of the five are
alive and none has required a subsequent re-operation in either
the short- or longterm. The PJ dehiscence was safely and defini-
tively addressed with the bridge stent procedure, which avoided
the multiple trips to the operating room that have been reported
with wide drainage alone.4 Furthermore, there has been no evi-
dence of PJ stricture development on a chronic basis by follow-up
imaging (dilated duct, glandular atrophy) or on clinical grounds
(recurrent pancreatitis, diabetes) in these patients.
Conclusions
Pancreaticojejunostomy anastomotic dehiscence following pan-
creaticoduodenectomy is a rare and difficult problem to manage.
Traditionally, re-exploration with completion pancreatectomy
and/or wide drainage has been employed, but this process carries
with it significant morbidity and mortality. In a compromised
patient, the goal remains the conducting of a safe, efficient
re-operation that allows meaningful recovery. Here, we have
described an alternative approach to the management of this for-
midable problem that has allowed a small group of patients to
recover sufficiently for hospital discharge with limited longterm
sequelae.
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